Stevanato Group S.p.A.

NYSE STVN

Stevanato Group S.p.A. Revenue for the year ending December 31, 2023: USD 1.20 B

Stevanato Group S.p.A. Revenue is USD 1.20 B for the year ending December 31, 2023, a 13.82% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.

Stevanato Group S.p.A. Revenue for the year ending December 31, 2022 was USD 1.05 B, a 9.56% change year over year.
Stevanato Group S.p.A. Revenue for the year ending December 31, 2021 was USD 960.65 M, a 18.79% change year over year.
Stevanato Group S.p.A. Revenue for the year ending December 31, 2020 was USD 808.72 M, a 34.31% change year over year.
Stevanato Group S.p.A. Revenue for the year ending December 31, 2019 was USD 602.12 M.

Key data

Date	Revenue	Gross Profit	Operating Income	EBIT

NYSE: STVN

Stevanato Group S.p.A.

CEO	Mr. Franco Stevanato
IPO Date	July 16, 2021
Location	Italy
Headquarters	Via Molinella, 17
Employees	5,635
Sector	Health Care
Industries Pharmaceuticals

Description

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. operates as a subsidiary of Stevanato Holding S.R.L.

Key trends

Past 5 years